KK
ABUS icon

KLP Kapitalforvaltning’s Arbutus Biopharma ABUS Stock Holding History

KLP Kapitalforvaltning’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$148K Hold
30,900
– – ﹤0.01% 2004
2026
Q1 		$139K Hold
30,900
– – ﹤0.01% 1955
2025
Q4 		$149K Buy
30,900
+5,300
+21% +$23.8K ﹤0.01% 1941
2025
Q3 		$116K Hold
25,600
– – ﹤0.01% 2024
2025
Q2 		$79.1K Hold
25,600
– – ﹤0.01% 2099
2025
Q1 		$89.3K Hold
25,600
– – ﹤0.01% 2063
2024
Q4 		$83.7K Buy
+25,600
New +$94.2K ﹤0.01% 2142

Other funds holding ABUS

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

KLP Kapitalforvaltning's ABUS Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Arbutus Biopharma (ABUS) position steady in Q2 2026 at 30,900 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #2004.

KLP Kapitalforvaltning first reported a position in ABUS in Q4 2024 and has held it in 7 quarters since. The position peaked at $149K in Q4 2025. 177 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

  • KLP Kapitalforvaltning held 30,900 shares of Arbutus Biopharma worth $148K as of Q2 2026.
  • KLP Kapitalforvaltning left its Arbutus Biopharma share count unchanged in Q2 2026.
  • Arbutus Biopharma made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #2004 holding.
  • KLP Kapitalforvaltning first reported a position in Arbutus Biopharma in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Arbutus Biopharma position peaked at $149K in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.